Medical Properties Trust Inc

Medical Properties Trust Inc(MPW)のニュースとイベント

$5.020

-0.030 (-0.59%)終値時点

MPW のニュース

MPW のイベント

11/17 08:56

Medical Properties Trust Raises Quarterly Dividend by 12% to $0.09 per Share

Medical Properties Trust announced that its board of directors declared a regular quarterly cash dividend of 9c per share of common stock to be paid on January 8, 2026, to stockholders of record on December 11.

10/30 09:06

Medical Properties Trust Announces Q3 EPS of 13 Cents, Below Consensus Estimate of 2 Cents

Reports Q3 revenue $237.52M, consensus $245.79M. Edward Aldag, Jr., chairman, president and CEO, said, "Our recently transitioned portfolio continues to ramp cash rents as expected. Following the successful re-tenanting of our California hospitals, we have increased confidence that pro rata annualized cash rent from our current portfolio will exceed $1 billion by the end of 2026."

9/29 08:10

Medical Properties Trust Offers Update on Portfolio

Medical Properties Trust provided updates with respect to certain hospitals currently leased to Prospect Medical as well as recent asset sales. Yale New Haven Health System has entered into a settlement agreement with Prospect and MPT under which Yale will pay $45 million to Prospect, while Prospect and MPT will release Yale of any obligation to purchase the three facilities in Connecticut that it agreed to purchase in 2022. MPT expects that the $45 million will be used to reduce the Company's outstanding debtor-in-possession loan to Prospect. The settlement remains subject to approval of the Bankruptcy Court overseeing Prospect's Chapter 11 case. In addition, with respect to the hospitals operated by Prospect in Connecticut, Prospect has entered into a definitive agreement with an operator to purchase two of the facilities and is in discussions with another operator to purchase the third facility. Those sales are also subject to Court approval. The $45 million settlement payment from Yale will be additive to proceeds from the sales of all three facilities

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める